Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 4
2015 4
2016 4
2017 6
2018 6
2019 8
2020 7
2021 10
2022 9
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Among authors: lopez causape c. Lancet Reg Health Eur. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37753216 Free PMC article.
Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients.
Diaz Caballero J, Wheatley RM, Kapel N, López-Causapé C, Van der Schalk T, Quinn A, Shaw LP, Ogunlana L, Recanatini C, Xavier BB, Timbermont L, Kluytmans J, Ruzin A, Esser M, Malhotra-Kumar S, Oliver A, MacLean RC. Diaz Caballero J, et al. Among authors: lopez causape c. Nat Commun. 2023 Jul 12;14(1):4083. doi: 10.1038/s41467-023-39416-2. Nat Commun. 2023. PMID: 37438338 Free PMC article.
The Versatile Mutational Resistome of Pseudomonas aeruginosa.
López-Causapé C, Cabot G, Del Barrio-Tofiño E, Oliver A. López-Causapé C, et al. Front Microbiol. 2018 Apr 6;9:685. doi: 10.3389/fmicb.2018.00685. eCollection 2018. Front Microbiol. 2018. PMID: 29681898 Free PMC article. Review.
Pseudomonasaeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group.
Oliver A, Rojo-Molinero E, Arca-Suarez J, Beşli Y, Bogaerts P, Cantón R, Cimen C, Croughs PD, Denis O, Giske CG, Graells T, Daniel Huang TD, Iorga BI, Karatuna O, Kocsis B, Kronenberg A, López-Causapé C, Malhotra-Kumar S, Martínez LM, Mazzariol A, Meyer S, Naas T, Notermans DW, Oteo-Iglesias J, Pedersen T, Pirš M, Poeta P, Poirel L, Pournaras S, Sundsfjord A, Szabó D, Tambić-Andrašević A, Vatcheva-Dobrevska R, Vitkauskienė A, Jeannot K; ESGARS-ISARPAE members. Oliver A, et al. Among authors: lopez causape c. Clin Microbiol Infect. 2024 Apr;30(4):469-480. doi: 10.1016/j.cmi.2023.12.026. Epub 2023 Dec 30. Clin Microbiol Infect. 2024. PMID: 38160753 Free article.
The increasing threat of Pseudomonas aeruginosa high-risk clones.
Oliver A, Mulet X, López-Causapé C, Juan C. Oliver A, et al. Among authors: lopez causape c. Drug Resist Updat. 2015 Jul-Aug;21-22:41-59. doi: 10.1016/j.drup.2015.08.002. Epub 2015 Aug 10. Drug Resist Updat. 2015. PMID: 26304792 Review.
Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial.
Torrens G, van der Schalk TE, Cortes-Lara S, Timbermont L, Del Barrio-Tofiño E, Xavier BB, Zamorano L, Lammens C, Ali O, Ruzin A, Goossens H, Kumar-Singh S, Kluytmans J, Paling F, MacLean RC, Köhler T, López-Causapé C, Malhotra-Kumar S, Oliver A; ASPIRE-ICU study team. Torrens G, et al. Among authors: lopez causape c. J Antimicrob Chemother. 2022 Jun 29;77(7):1862-1872. doi: 10.1093/jac/dkac122. J Antimicrob Chemother. 2022. PMID: 35451008 Clinical Trial.
66 results